{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T06:36:23Z","timestamp":1770446183146,"version":"3.49.0"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","lrjournal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Leukemia Research"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1016\/j.leukres.2016.08.008","type":"journal-article","created":{"date-parts":[[2016,8,15]],"date-time":"2016-08-15T08:00:48Z","timestamp":1471248048000},"page":"51-59","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Bone marrow B lymphocytes in multiple myeloma and MGUS: Focus on distribution of na\u00efve cells and memory subsets"],"prefix":"10.1016","volume":"49","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4971-240X","authenticated-orcid":false,"given":"Fanny","family":"Pojero","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandra","family":"Casuccio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caterina","family":"Giambanco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matteo","family":"Bulati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvio","family":"Buffa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Di Bassiano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Gervasi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Calogero","family":"Caruso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppina","family":"Colonna Romano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"Suppl 6","key":"10.1016\/j.leukres.2016.08.008_bib0005","doi-asserted-by":"crossref","DOI":"10.1093\/annonc\/mdt297","article-title":"ESMO guidelines working group. Multiple myeloma: ESMO clinical practice guidelines for diagnosis, treatment and follow-up","volume":"24","author":"Moreau","year":"2013","journal-title":"Ann. Oncol."},{"issue":"Suppl 1","key":"10.1016\/j.leukres.2016.08.008_bib0010","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/S0145-2126(12)70003-6","article-title":"Can we change the disease biology of multiple myeloma?","volume":"36","author":"Borrello","year":"2012","journal-title":"Leuk. Res."},{"issue":"Oct (10)","key":"10.1016\/j.leukres.2016.08.008_bib0015","doi-asserted-by":"crossref","first-page":"3456","DOI":"10.1172\/JCI61188","article-title":"Molecular pathogenesis of multiple myeloma and its premalignant precursor","volume":"122","author":"Kuehl","year":"2012","journal-title":"J. Clin. Invest."},{"issue":"September (9)","key":"10.1016\/j.leukres.2016.08.008_bib0020","doi-asserted-by":"crossref","first-page":"e25619","DOI":"10.4161\/onci.25619","article-title":"Contribution of regulatory T cells to immunosuppression and disease progression in multiple myeloma patients","volume":"2","author":"Raja","year":"2013","journal-title":"Oncoimmunology"},{"issue":"May (27)","key":"10.1016\/j.leukres.2016.08.008_bib0025","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.blre.2013.04.004","article-title":"Regulating the regulators in cancer-immunosuppression in multiple myeloma (MM)","volume":"3","author":"Feyler","year":"2013","journal-title":"Blood Rev."},{"issue":"May (12)","key":"10.1016\/j.leukres.2016.08.008_bib0030","first-page":"1","article-title":"Myeloid derived suppressor cells are numerically, functionally and phenotypically different in patients with multiple myeloma","author":"Favaloro","year":"2014","journal-title":"Leuk. Lymphoma"},{"issue":"July (18)","key":"10.1016\/j.leukres.2016.08.008_bib0035","article-title":"The alteration and clinical significance of Th1\/Th2\/Th17\/Treg cells in patients with multiple myeloma","author":"Feng","year":"2014","journal-title":"Inflammation"},{"issue":"April (4)","key":"10.1016\/j.leukres.2016.08.008_bib0040","doi-asserted-by":"crossref","first-page":"e61","DOI":"10.1016\/j.clml.2014.12.003","article-title":"Analysis of B-cell subpopulations in monoclonal gammopathies","author":"V\u0161iansk\u00e1","year":"2015","journal-title":"Clin. Lymphoma Myeloma Leuk."},{"issue":"June (3)","key":"10.1016\/j.leukres.2016.08.008_bib0045","first-page":"257","article-title":"Immune defects in the risk of infection and response to vaccination in monoclonal gammopathy of undetermined significance and multiple myeloma","volume":"5","author":"Tete","year":"2014","journal-title":"Front. Immunol."},{"issue":"April (11)","key":"10.1016\/j.leukres.2016.08.008_bib0050","first-page":"196063","article-title":"Targeting multiple-myeloma-induced immune dysfunction to improve immunotherapy outcomes","volume":"2012","author":"Rutella","year":"2012","journal-title":"Clin. Dev. Immunol."},{"issue":"October (8)","key":"10.1016\/j.leukres.2016.08.008_bib0055","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1086\/605664","article-title":"Infections in patients with multiple myeloma in the era of high-dose therapy and novel agents","volume":"49","author":"Nucci","year":"2009","journal-title":"Clin. Infect. Dis."},{"issue":"May (5)","key":"10.1016\/j.leukres.2016.08.008_bib0060","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1007\/s11427-013-4478-0","article-title":"Immunosenescence and age-related viral diseases","volume":"56","author":"Ma","year":"2013","journal-title":"Sci. China Life Sci."},{"issue":"April (2)","key":"10.1016\/j.leukres.2016.08.008_bib0065","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.arr.2010.12.002","article-title":"B cells and immunosenescence: a focus on IgG + IgD-CD27- (DN) B cells in aged humans","volume":"10","author":"Bulati","year":"2011","journal-title":"Ageing Res. Rev."},{"issue":"October (10)","key":"10.1016\/j.leukres.2016.08.008_bib0070","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.mad.2009.08.003","article-title":"A double-negative (IgD-CD27-) B cell population is increased in the peripheral blood of elderly people","volume":"130","author":"Colonna-Romano","year":"2009","journal-title":"Mech. Ageing Dev."},{"issue":"June","key":"10.1016\/j.leukres.2016.08.008_bib0075","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.exger.2013.12.011","article-title":"Trafficking phenotype and production of granzyme B by double negative B cells (IgG(+)IgD(\u2212)CD27(\u2212)) in the elderly","volume":"54","author":"Bulati","year":"2014","journal-title":"Exp. Gerontol."},{"issue":"October (5)","key":"10.1016\/j.leukres.2016.08.008_bib0080","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1007\/s10522-011-9353-4","article-title":"B cell immunosenescence: different features of naive and memory B cells in elderly","volume":"12","author":"Buffa","year":"2011","journal-title":"Biogerontology"},{"issue":"November (22)","key":"10.1016\/j.leukres.2016.08.008_bib0085","doi-asserted-by":"crossref","first-page":"6155","DOI":"10.1158\/1078-0432.CCR-12-0531","article-title":"Stemness of B-cell progenitors in multiple myeloma bone marrow","volume":"15","author":"Boucher","year":"2012","journal-title":"Clin. Cancer Res."},{"issue":"January (1)","key":"10.1016\/j.leukres.2016.08.008_bib0090","doi-asserted-by":"crossref","first-page":"155","DOI":"10.3324\/haematol.2013.092817","article-title":"Circulating clonotypic B cells in multiple myeloma and monoclonal gammopathy of undetermined significance","volume":"99","author":"Thiago","year":"2014","journal-title":"Haematologica"},{"issue":"September (9)","key":"10.1016\/j.leukres.2016.08.008_bib0095","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1038\/leu.2012.80","article-title":"CD138-negative clonogenic cells are plasma cells but not B cells in some multiple myeloma patients","volume":"26","author":"Hosen","year":"2012","journal-title":"Leukemia"},{"issue":"June (23)","key":"10.1016\/j.leukres.2016.08.008_bib0100","doi-asserted-by":"crossref","first-page":"3618","DOI":"10.1182\/blood-2014-02-556746","article-title":"Next-generation sequencing of peripheral B-lineage cells pinpoints the circulating clonotypic cell pool in multiple myeloma","volume":"123","author":"Thiele","year":"2014","journal-title":"Blood"},{"issue":"October (10)","key":"10.1016\/j.leukres.2016.08.008_bib0105","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.5858\/133.10.1594","article-title":"Phenotyping studies of clonotypic B lymphocytes from patients with multiple myeloma by flow cytometry","volume":"133","author":"Conway","year":"2009","journal-title":"Arch. Pathol. Lab. Med."},{"issue":"September (3)","key":"10.1016\/j.leukres.2016.08.008_bib0110","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1002\/1097-0142(197509)36:3<842::AID-CNCR2820360303>3.0.CO;2-U","article-title":"A clinical staging system for multiple myeloma. Correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survival","volume":"36","author":"Durie","year":"1975","journal-title":"Cancer Sep."},{"issue":"May (15)","key":"10.1016\/j.leukres.2016.08.008_bib0115","doi-asserted-by":"crossref","first-page":"3412","DOI":"10.1200\/JCO.2005.04.242","article-title":"International staging system for multiple myeloma","volume":"23","author":"Greipp","year":"2005","journal-title":"J. Clin. Oncol."},{"issue":"July (1)","key":"10.1016\/j.leukres.2016.08.008_bib0120","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1111\/j.1365-2141.2011.08573.x","article-title":"Guidelines for the diagnosis and management of multiple myeloma 2011","volume":"154","author":"Bird","year":"2011","journal-title":"Br. J. Haematol."},{"issue":"3","key":"10.1016\/j.leukres.2016.08.008_bib0125","doi-asserted-by":"crossref","first-page":"431","DOI":"10.3324\/haematol.11080","article-title":"European Myeloma Network. Report of the European Myeloma Network on multiparametric flow cytometry in multiple myeloma and related disorders","volume":"10","author":"Rawstron","year":"2008","journal-title":"Haematologica"},{"issue":"May (3)","key":"10.1016\/j.leukres.2016.08.008_bib0130","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1111\/j.1365-2141.2010.08121.x","article-title":"Review of phenotypic markers used in flow cytometric analysis of MGUS and MM, and applicability of flow cytometry in other plasma cell disorders","volume":"149","author":"Raja","year":"2010","journal-title":"Br. J. Haematol."},{"issue":"September (9)","key":"10.1016\/j.leukres.2016.08.008_bib0135","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1038\/sj.leu.2404815","article-title":"A single-tube six-colour flow cytometry screening assay for the detection of minimal residual disease in myeloma","volume":"21","author":"de Tute","year":"2007","journal-title":"Leukemia"},{"key":"10.1016\/j.leukres.2016.08.008_bib0140","article-title":"Blood and Bone Marrow Pathology","year":"2011"},{"issue":"October (3)","key":"10.1016\/j.leukres.2016.08.008_bib0145","article-title":"Advances in human B cell phenotypic profiling","volume":"302","author":"Kaminski","year":"2012","journal-title":"Front. Immunol."},{"issue":"September (3)","key":"10.1016\/j.leukres.2016.08.008_bib0150","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.beha.2010.09.002","article-title":"Immunophenotyping in multiple myeloma and related plasma cell disorders","volume":"23","author":"Kumar","year":"2010","journal-title":"Best Pract. Res. Clin. Haematol."},{"issue":"November (6)","key":"10.1016\/j.leukres.2016.08.008_bib0155","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1002\/cyto.b.20485","article-title":"Considerations for the control of background fluorescence in clinical flow cytometry","volume":"76","author":"Hulspas","year":"2009","journal-title":"Cytometry B Clin. Cytom."},{"issue":"May (8)","key":"10.1016\/j.leukres.2016.08.008_bib0160","article-title":"Molecular pathogenesis of multiple myeloma","author":"Furukawa","year":"2015","journal-title":"Int. J. Clin. Oncol."},{"issue":"January (1)","key":"10.1016\/j.leukres.2016.08.008_bib0165","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1073\/pnas.94.1.208","article-title":"Memory B lymphocytes migrate to bone marrow in humans","volume":"94","author":"Paramithiotis","year":"1997","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"January (2)","key":"10.1016\/j.leukres.2016.08.008_bib0170","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1002\/(SICI)1097-0258(19990130)18:2<223::AID-SIM998>3.0.CO;2-G","article-title":"B lymphocyte migration to the bone marrow of humans is not random","volume":"18","author":"Mayo","year":"1999","journal-title":"Stat. Med."},{"issue":"July (7)","key":"10.1016\/j.leukres.2016.08.008_bib0175","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.it.2009.04.005","article-title":"B cells and aging: molecules and mechanisms","volume":"7","author":"Cancro","year":"2009","journal-title":"Trends Immunol."},{"issue":"July (3)","key":"10.1016\/j.leukres.2016.08.008_bib0180","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.arr.2010.08.004","article-title":"Age effects on B cells and humoral immunity in humans","volume":"3","author":"Frasca","year":"2011","journal-title":"Ageing Res. Rev."},{"issue":"77","key":"10.1016\/j.leukres.2016.08.008_bib0185","article-title":"Exploiting human memory B cell heterogeneity for improved vaccine efficacy","volume":"2","author":"Pauli","year":"2011","journal-title":"Front. Immunol."},{"issue":"August (8)","key":"10.1016\/j.leukres.2016.08.008_bib0190","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1002\/eji.200939531","article-title":"Memory B cells: effectors of long-lived immune responses","volume":"39","author":"Tangye","year":"2009","journal-title":"Eur. J. Immunol."},{"issue":"July (1)","key":"10.1016\/j.leukres.2016.08.008_bib0195","doi-asserted-by":"crossref","first-page":"13","DOI":"10.4049\/jimmunol.179.1.13","article-title":"Human IgM + CD27+ b cells: memory b cells or memory B cells?","volume":"179","author":"Tangye","year":"2007","journal-title":"J. Immunol."},{"issue":"May (152)","key":"10.1016\/j.leukres.2016.08.008_bib0200","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.imlet.2013.04.007","article-title":"Why do we need IgM memory B cells?","volume":"2","author":"Capolunghi","year":"2013","journal-title":"Immunol. Lett."},{"issue":"Dec (67)","key":"10.1016\/j.leukres.2016.08.008_bib0205","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1016\/j.humimm.2006.10.008","article-title":"Role of tonsillar IgD + CD27+ memory B cells in humoral immunity against pneumococcal infection","volume":"12","author":"Takizawa","year":"2006","journal-title":"Hum. Immunol."},{"issue":"May (10)","key":"10.1016\/j.leukres.2016.08.008_bib0210","doi-asserted-by":"crossref","first-page":"6624","DOI":"10.4049\/jimmunol.178.10.6624","article-title":"A new population of cells lacking expression of CD27 represents a notable component of the B cell memory compartment in systemic lupus erythematosus","volume":"178","author":"Wei","year":"2007","journal-title":"J. Immunol."},{"issue":"Aug (8)","key":"10.1016\/j.leukres.2016.08.008_bib0215","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1084\/jem.20072683","article-title":"Evidence for HIV-associated B cell exhaustion in a dysfunctional memory B cell compartment in HIV-infected viremic individuals","volume":"205","author":"Moir","year":"2008","journal-title":"J. Exp. Med."},{"issue":"5","key":"10.1016\/j.leukres.2016.08.008_bib0220","doi-asserted-by":"crossref","first-page":"e5427","DOI":"10.1371\/journal.pone.0005427","article-title":"CD27(\u2212) B-cells produce class switched and somatically hyper-mutated antibodies during chronic HIV-1 infection","volume":"4","author":"Cagigi","year":"2009","journal-title":"PLoS One"},{"issue":"December (2)","key":"10.1016\/j.leukres.2016.08.008_bib0225","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.clim.2013.12.001","article-title":"Peripheral CD27-CD21- B-cells represent an exhausted lymphocyte population in hepatitis C cirrhosis","volume":"150","author":"Doi","year":"2014","journal-title":"Clin. Immunol."},{"issue":"December (24)","key":"10.1016\/j.leukres.2016.08.008_bib0230","doi-asserted-by":"crossref","first-page":"4850","DOI":"10.1182\/blood-2012-05-430959","article-title":"Humans with chronic granulomatous disease maintain humoral immunologic memory despite low frequencies of circulating memory B cells","volume":"120","author":"Moir","year":"2012","journal-title":"Blood"},{"issue":"July (7)","key":"10.1016\/j.leukres.2016.08.008_bib0235","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/j.humimm.2013.04.007","article-title":"Derailed B cell homeostasis in patients with mixed connective tissue disease","volume":"74","author":"Hajas","year":"2013","journal-title":"Hum. Immunol."},{"issue":"September (6)","key":"10.1016\/j.leukres.2016.08.008_bib0240","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1084\/jem.20050879","article-title":"Expression of the immunoregulatory molecule FcRH4 defines a distinctive tissue-based population of memory B cells","volume":"202","author":"Ehrhardt","year":"2005","journal-title":"J. Exp. Med."},{"issue":"June (12)","key":"10.1016\/j.leukres.2016.08.008_bib0245","doi-asserted-by":"crossref","first-page":"3281","DOI":"10.1158\/1078-0432.CCR-12-0234","article-title":"CD20+ tumor-infiltrating lymphocytes have an atypical CD27- memory phenotype and together with CD8+ T cells promote favorable prognosis in ovarian cancer","volume":"18","author":"Nielsen","year":"2012","journal-title":"Clin. Cancer Res."}],"container-title":["Leukemia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212616301722?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212616301722?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,7,5]],"date-time":"2022-07-05T23:53:08Z","timestamp":1657065188000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0145212616301722"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10]]},"references-count":49,"alternative-id":["S0145212616301722"],"URL":"https:\/\/doi.org\/10.1016\/j.leukres.2016.08.008","relation":{},"ISSN":["0145-2126"],"issn-type":[{"value":"0145-2126","type":"print"}],"subject":[],"published":{"date-parts":[[2016,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bone marrow B lymphocytes in multiple myeloma and MGUS: Focus on distribution of na\u00efve cells and memory subsets","name":"articletitle","label":"Article Title"},{"value":"Leukemia Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.leukres.2016.08.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}